Navigation Links
Cumberland Pharmaceuticals Appoints Rick S. Greene Chief Financial Officer
Date:10/12/2011

on products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's product portfolio includes Acetadote® (acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor® (ibuprofen) Injection, the first injectable treatment for pain and fever approved in the United States, and Kristalose® (lactulose) for Oral Solution, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information on Cumberland, please visit the Company's website at www.cumberlandpharma.com.

Forward-Looking Statements

This press release contains forward-looking statements, which are subject to certain risks and reflect Cumberland's current views on future events based on what it believes are reasonable assumptions. No assurance can be given that these events will occur. As with any business, all phases of Cumberland's operations are subject to factors outside its control, and any one or combination of these factors could materially affect Cumberland's results of operations. These factors include market conditions, competition, an inability of manufacturers to produce Cumberland's products on a timely basis or a failure of manufacturers to comply with regulations applicable to pharmaceutical manufacturers, maintaining an effective sales and marketing infrastructure and other factors discussed in the Company's 2010 Annual Report on Form 10-K filed with the SEC on March 11, 2011. There can be no assurance that results anticipated by the Company will be realized or that they will have the expected effects. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to publicly revise these statements to reflect events after the date hereof.

'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference In New York
2. Cumberland Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference in Boston
3. Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results
4. Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America
5. Cumberland Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
6. Cumberland Pharmaceuticals to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
7. Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results
8. Cumberland Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011
9. Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection
10. Cumberland Pharmaceuticals Appoints Rick S. Greene as Vice President, Finance & Accounting
11. Cumberland Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 A new ... cardiovascular monitoring and diagnostic devices market stood at ... reach a value of approximately US$7.0 billion in ... 2013 and 2019. The title of the report ... Holter Monitors, Event Monitors, Cardiovascular Diagnostic Catheters, Implantable ...
(Date:8/31/2015)... 2015  On August 5, 2015, the U.S. District ... denied motions to dismiss securities class action claims ... certain of its directors. The class actions allege that ... scheme to artificially inflate Galena,s stock price, and during ... was inflated, sold massive amounts of their personally-held shares. ...
(Date:8/31/2015)... , Aug. 31, 2015  Regulatory affairs professionals ... where regulations are often strict and legislation is ... a demand for professionals who have a deep ... across a product lifecycle and demonstrate its use ... University of California, Irvine Extension , in partnership ...
Breaking Medicine Technology:Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3
... Inotek,Pharmaceuticals Corporation announced today the presentation of,positive ... of INO-1001,as well as the potential for ... injury. The study was conducted in subjects,with ... coronary intervention. The presentation was,made in a ...
... announced today,that Lipitor(R) (atorvastatin calcium) Tablets (80 mg) ... events in patients with heart disease, according to,two ... the,annual meeting of the American College of Cardiology., ... the availability,of low cost generics, intensive Lipitor therapy ...
Cached Medicine Technology:Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 2Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 4Lipitor Significantly Lowered Hospitalization Costs for Patients,with Heart Disease, Two New Analyses Show 2Lipitor Significantly Lowered Hospitalization Costs for Patients,with Heart Disease, Two New Analyses Show 3Lipitor Significantly Lowered Hospitalization Costs for Patients,with Heart Disease, Two New Analyses Show 4
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... and digital marketing communications company announced today that it has officially launched a ... President, the new website and brand refresh are more closely aligned with the ...
(Date:8/31/2015)... Illinois (PRWEB) , ... August 31, 2015 , ... ... their AdvantaClean franchise business with a ribbon-cutting ceremony on Aug. 26, generously hosted ... calls and booking inspection appointments via AdvantaClean’s National Call Center and website since ...
(Date:8/31/2015)... ... 31, 2015 , ... Physicians’ Education Resource®, LLC (PER®) ... Innovative Cancer Therapy for Tomorrow® meeting, is seeking abstract submissions for its ... City. The annual legacy meeting uses a variety of formats to educate all ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... peers may be at a greater risk for injury, potentially because they are ... University of Pittsburgh Graduate School of Public Health analysis discovered. , The ...
(Date:8/31/2015)... ... August 31, 2015 , ... On Saturday, May 30th, ... at the Adams County Fairgrounds in Mendon, IL. The purpose behind this concert was ... Mendon and neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music with a Mission” ...
Breaking Medicine News(10 mins):Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3
... really mysterious, however these have inspired a computational technique ... affected by the// personality disorder schizophrenia. Researchers feel the ... that can help diagnose the condition. ,Exactly ... schizophrenia is yet to be pinned down. Raymond Deicken ...
... abuse can be moderately improved by various psychotherapy treatments ... the best clinicians// can hope for at this time, ... behavioral therapy (CBT) is most effective, but other counseling ... social problems associated with their marijuana use. ...
... and Clinical Excellence (NICE) has brought out guidance to ... to help adult patients suffering acute plaque psoriasis. Despite ... benefits for many patients in Europe due to the ... for many thousands of patients across United Kingdom who ...
... research done by Eyal Raz, Sandip Datta and Joshua ... Medicine it was found that gamma radiation// killed bacteria ... against the bacterial disease. ,The U.S. National ... researches in their finding and said that these bacterial ...
... who completed a management course here and agreed to be part ... effects of the trial and is looking// forward to returning to ... trial for US testing firm Parexel in March, but is now ... He is reported to be taking antidepressants and medication to stop ...
... which a specific cell protein trigger the spread of cancer ... by researchers in the Cell Signalling Unit, University of Edinburgh ... which limit the protein's ability to turn a normal cell ... the activity of a key cancer preventing protein called p53. ...
Cached Medicine News:Health News:Diagnosing Schizophrenia 2Health News:Marijuana Abuse Responds to Psychotherapy, Overall Is Hard to Treat 2Health News:Marijuana Abuse Responds to Psychotherapy, Overall Is Hard to Treat 3Health News:NICE supports application of advanced biological therapies as treatment option for acute psoriasis 2Health News:NICE supports application of advanced biological therapies as treatment option for acute psoriasis 3Health News:NICE supports application of advanced biological therapies as treatment option for acute psoriasis 4
Ideal for abdominal procedures...
For lipoplasty of trochanteric region, abdomen, thighs, hips/flanks, buttocks, knees, calves and ankles...
CDIs original garments with our exclusive Wonderfabric™....
Short Girdle, Mid-thigh, Front Closure...
Medicine Products: